Signature Equity Partners’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.29K Sell
265
-69
-21% -$2.27K ﹤0.01% 907
2026
Q1
$12.4K Buy
334
+70
+27% +$2.88K 0.01% 763
2025
Q4
$12.4K Buy
+264
New +$11.4K 0.01% 779

Other funds holding G

Signature Equity Partners's G Position: Q2 2026 in Review

Signature Equity Partners reduced its Genpact (G) stake by 21% in Q2 2026, selling an estimated $2.27K and leaving 265 shares worth $7.29K. The position accounts for ﹤0.01% of the portfolio, ranked #907.

Signature Equity Partners first reported a position in G in Q4 2025 and has held it in 3 quarters since. The position peaked at $12.4K in Q1 2026. 479 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • Signature Equity Partners held 265 shares of Genpact worth $7.29K as of Q2 2026.
  • Signature Equity Partners sold 69 Genpact shares in Q2 2026, an estimated $2.27K.
  • Genpact made up ﹤0.01% of Signature Equity Partners's portfolio in Q2 2026, its #907 holding.
  • Signature Equity Partners first reported a position in Genpact in Q4 2025 and has held it in 3 quarters since.
  • Signature Equity Partners's Genpact position peaked at $12.4K in Q1 2026.
  • 479 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.